Scientific Session
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Michael Hughes, PhD, MBBS, BSc, MSc, MRCP
Tameside and Glossop Integrated NHS Foundation Trust & The University of Manchester
Manchester, United Kingdom
Disclosure: Disclosure(s): Actelion pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 1, 2021); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 1, 2021); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 1, 2021)